Frederic Houssiau

Title: Frederic Houssiau: Innovator in Cell Apoptosis Modulation

Introduction

Frederic Houssiau is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly in the modulation of cell apoptosis. His innovative work has implications for understanding and treating various diseases, including cancer.

Latest Patents

Houssiau holds a patent for a "Method for modulating cell apoptosis." This invention is based on the newly recognized ability of beta chemokines to inhibit cell apoptosis, specifically focusing on T cells. The known beta chemokines I-309 and TCA-3 are examples that inhibit apoptosis. One aspect of his invention involves using these molecules to inhibit apoptosis, while another aspect explores the use of beta chemokine inhibitors or antagonists to provoke apoptosis. He has 1 patent to his name.

Career Highlights

Frederic Houssiau is associated with the Ludwig Institute for Cancer Research Limited, where he conducts his research. His work has been pivotal in advancing the understanding of cell death mechanisms, which is crucial for developing new therapeutic strategies.

Collaborations

Houssiau has collaborated with esteemed colleagues such as Jo Van Damme and Paul Proost. These collaborations have enriched his research and contributed to the advancement of knowledge in the field of cancer research.

Conclusion

Frederic Houssiau's innovative work in modulating cell apoptosis highlights his significant contributions to cancer research. His patent and collaborations reflect his commitment to advancing scientific understanding and developing potential therapeutic applications.